title: Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologist.
authors.affiliation: NYU, USA.
authors.forename: Theodore
authors.initials: T
authors.lastname: Pincus
authors.forename: Juergen
authors.initials: J
authors.lastname: Braun
authors.forename: Arthur
authors.initials: A
authors.lastname: Kavanaugh
authors.forename: Josef S
authors.initials: JS
authors.lastname: Smolen
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001688:Biological Products / Q000008:administration & dosage; D003142:Communication; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D010358:Patient Participation; D010817:Physician-Patient Relations; D012008:Recurrence; D012074:Remission Induction; D012216:Rheumatic Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D007166:Immunosuppressive Agents